Home > Healthcare & Medical Devices > Prurigo Nodularis Treatment Market

Prurigo Nodularis Treatment Market Size By Product (Antihistamines, Capsaicin Cream, Corticosteroids, Emollients), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies), Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2021 - 2027

  • Report ID: GMI3849
  • Published Date: Apr 2021
  • Report Format: PDF

Industry trends

Prurigo Nodularis Treatment Market size was valued at more than USD 1 billion in 2020 and is estimated to grow at over 5.2% CAGR between 2021 and 2027. Growing incidence of prurigo nodularis has considerably driven the demand for effective treatment therapeutics in order to contain the spread of this rare disease. This disease is more prevalent in the age group 20 to 60 years, especially in the population already suffering from atopic dermatitis. Additionally, rising R&D activities for drug development across the globe has created opportunities for the market.

Prurigo Nodularis Treatment Market Overview

Get more details on this report - Request Free Sample PDF

Prurigo nodularis (PN) is a dermal condition causing hard crusty lumps on the skin that itches intensely. Prurigo nodularis imparts constant itch along with excessive redness on the affected area. Factors triggering PN caused nervous and mental conditions, reduced function of the liver and kidneys, and skin diseases such as eczema, bullous pemphigoid and dermatitis herpetiformis.

Prurigo nodularis is a rare disease and currently the treatment is in research and development process. Various firms are working on novel therapies to reduce the prevalence of the disease. In addition, growing awareness among population and rising funding from government and major market players for research and development activities will accelerate the market growth during the forecast period.

Advancements in research and development activities for new product development will stimulate the prurigo nodularis treatment market expansion

Advancements in prurigo nodularis treatment research activities will enhance the market revenue. Pharmaceutical companies are continuously emphasizing on research and development of drug and therapies to offer effective results in treatment process. Additionally, development of cost-effective drugs further boosts the product demand in the market. Moreover, various collaborations between non-government organizations and key players for the R&D will further augment the industry growth. However, concerns associated with lack of expertise related to treatment process and lack of effective targeted therapy will moderately affect the market demand during the forecast timeframe.

Improved results in oppressing itching and redness by the use of corticosteroids will strengthen the segment growth

Corticosteroids segment accounted for about 35% of revenue share in 2020, led by its higher adoption during treatment of prurigo nodularis treatment. Corticosteroid drugs helps in reducing the inflammation in the body. Furthermore, this drug class also eases the redness, itchiness and swelling during the course of this disease. Thus, preference for the product during prurigo nodularis treatment owing to aforementioned benefits will fuel the segment revenue in the foreseeable future.

Easy availability of cost-effective products through retail pharmacies will impel product demand

Prurigo Nodularis Treatment Market Size

Get more details on this report - Request Free Sample PDF


Retail pharmacies segment captured more than 40% of the prurigo nodularis treatment market share in 2020. Easy availability and cost-effectiveness of medicines will increase the demand for products via retail pharmacies in the future. Increasing incidence and awareness about prurigo nodularis has also influenced the demand of various over-the-counter drugs, creams and ointments among other products for better treatment.

Increasing research activities for development of novel biologics and presence of major market players will stimulate the growth for North America region

North America Prurigo Nodularis Treatment Market

Get more details on this report - Request Free Sample PDF


North America prurigo nodularis treatment market held over USD 380 million in 2020 on account of presence of major industry leaders, rising R&D expenditure, focus on product innovation, and increasing prevalence of dermatological diseases.

Rising government funding to boost the R&D for development of drugs and therapies will further foster the regional growth. Thus, extensive research and development activities to develop novel biological drugs will drive the North America market value in the coming years.

Prominent industry participants are focusing on product launch and approvals that will spur their market growth

Some of the leading companies operating in the market include Johnson & Johnson Services Inc., Pfizer Inc., Merck & Co. Inc., Sanofi, Teva Pharmaceuticals and GlaxoSmithKline plc. These industry players are adopting various inorganic growth strategies to obtain competitive advantage and strengthen their market position.

Some of the recent industry developments:

  • In May 2020, FDA approved Dupixent (dupilumab) by Sanofi for moderate to severe atopic dermatitis in children. This strategy helped the company in setting footprint in the market.

This market research report on prurigo nodularis treatment includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2016 to 2027 for the following segments:

Market, By Product

  • Antihistamines
  • Capsaicin Cream
  • Corticosteroids
  • Emollients
  • Others

Market, By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
Authors: Sumant Ugalmugle, Rupali Swain

Frequently Asked Questions (FAQ) :

The global prurigo nodularis treatment market size reached over USD 1 billion in 2020 and will grow at a CAGR of 5.2% up to 2027.

Corticosteroids held nearly 35% of the total market revenue in 2020 and will expand with surging use of corticosteroid drugs for the reduction of inflammation in human body.

North America prurigo nodularis treatment industry was over USD 380 million in 2020 and will depict remarkable growth due to the rising prevalence of dermatological diseases and increasing R&D expenditure.

The retail pharmacies segment held over 40% of the total industry share in 2020 and will grow further, driven by the soaring awareness about prurigo nodularis and the easy availability of medicines.

Buy Now

Access to only 1 person; cannot be shared; cannot be printed
Access for 2 to 5 users only within same department of one company
Access to a company wide audience; includes subsidiary companies or other companies within a group of companies
Immediate Delivery Available

Premium Report Details

  • Base Year: 2020
  • Companies covered: 9
  • Tables & Figures: 129
  • Countries covered: 15
  • Pages: 110

Get a report that explains COVID-19 impact on this market

 Request Free Sample

Budget constraints? Get in touch with us for special pricing

Request Discount